bpc-157 human trials 2025 trial clinical back pain BPC-157 For Knee Pain: Early Reported Outcomes, A BPC-157 – No Proof Required! – bpc-157 human clinical trial safety – bpc-157 human clinical trial tendon

Some research supports oral use of BPC-157, especially for gut healing applicationswhich makes sense given that it's derived from a gastric protein

It was first described in the scientific literature in 1993 by Sikiri and colleagues

The injection itself is administered intramuscularly, typically in the upper arm or hip area

Who Is a Good Candidate for BPC-157

No Observed Effects On: Blood glucose or insulin sensitivity (no diabetogenic effects) IGF-1 levels (remained within normal ranges) Blood pressure or cardiovascular parameters Thyroid function Liver or kidney function markers Important: The absence of growth hormone-related side effects distinguishes AOD-9604 from full-length GH, which can cause fluid retention, joint pain, carpal tunnel syndrome, and insulin resistance

Get the details and our analysis in the Cardiovascular section of the Dark Chocolate, Cocoa Powder, and Nibs Review